Brief: Sutro Biopharma To Provide Data Update On Stro-002 And Plans For Registrational Path Forward In Advanced Ovarian Cancer
21/12/2022 13:07
Dec 21 (Reuters) - Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA TO PROVIDE DATA UPDATE ON STRO-002 AND
PLANS FOR
REGISTRATIONAL PATH FORWARD IN ADVANCED OVARIAN CANCER
Source text for Eikon: ID:nGNX5X16hd
Further company coverage: STRO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates